π
|
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
28 auth.
M. Gillison,
A. Trotti,
J. Harris,
A. Eisbruch,
P. Harari,
D. Adelstein,
R. Jordan,
Weiqiang Zhao,
E. Sturgis,
B. Burtness,
J. Ridge,
J. Ringash,
J. Galvin,
M. Yao,
S. Koyfman,
...
D. Blakaj,
Mohammed A. Razaq,
A. Colevas,
J. Beitler,
Christopher U. Jones,
N. Dunlap,
S. Seaward,
S. Spencer,
T. Galloway,
J. Phan,
J. Dignam,
J. Dignam,
Q. Le
|
9 |
2019 |
9 π
|
π
|
Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)
22 auth.
S. Yom,
P. Torres-Saavedra,
J. Caudell,
J. Waldron,
M. Gillison,
P. Xia,
M. Truong,
C. Kong,
R. Jordan,
R. Subramaniam,
...
M. Yao,
C. Chung,
J. Geiger,
J. Chan,
B. O'Sullivan,
D. Blakaj,
L. Mell,
W. Thorstad,
Christopher U. Jones,
R. Banerjee,
C. Lominska,
Q. Le
|
7 |
2021 |
7 π
|
π
|
Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer
27 auth.
C. Anderson,
Christopher M. Lee,
D. Saunders,
A. Curtis,
N. Dunlap,
C. Nangia,
A. Lee,
S. Gordon,
P. Kovoor,
R. Arevalo-Araujo,
V. Bar-ad,
A. Peddada,
K. Colvett,
Douglas Miller,
A. K. Jain,
...
J. Wheeler,
D. Blakaj,
M. Bonomi,
S. Agarwala,
M. Garg,
F. Worden,
J. Holmlund,
J. Brill,
M. Downs,
S. Sonis,
S. Katz,
J. Buatti
|
6 |
2019 |
6 π
|
π’
|
Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data.
A. Blakaj,
M. Bonomi,
M. Gamez,
D. Blakaj
|
6 |
2019 |
6 π’
|
π
|
Time to Surgery and Survival in Head and Neck Cancer
15 auth.
C. Rygalski,
Songzhu Zhao,
A. Eskander,
Kevin Y. Zhan,
E. Mroz,
G. Brock,
Dustin A Silverman,
D. Blakaj,
M. Bonomi,
R. Carrau,
...
M. Old,
J. Rocco,
Nolan B. Seim,
Sidharth V. Puram,
Stephen Y. Kang
|
6 |
2020 |
6 π
|
π
|
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial
36 auth.
Sungjune Kim,
E. Wuthrick,
D. Blakaj,
Z. Eroglu,
C. Verschraegen,
R. Thapa,
M. Mills,
Khaled Dibs,
C. Liveringhouse,
J. Russell,
J. Caudell,
A. Tarhini,
J. Markowitz,
K. Kendra,
Richard Wu,
...
Dung-tsa Chen,
A. Berglund,
Lauren Michael,
M. Aoki,
Minhsuan Wang,
I. Hamaidi,
P. Cheng,
J. D. L. Iglesia,
R. Slebos,
C. Chung,
T. Knepper,
Carlos M. MorΓ‘n-Segura,
Jonathan V Nguyen,
B. Perez,
T. Rose,
L. Harrison,
J. Messina,
V. Sondak,
K. Tsai,
N. Khushalani,
A. Brohl
|
5 |
2022 |
5 π
|
π
|
Single-Isocenter Multitarget Stereotactic Radiosurgery Is Safe and Effective in the Treatment of Multiple Brain Metastases
17 auth.
J. Palmer,
N. Sebastian,
Jacquline Chu,
D. DiCostanzo,
E. Bell,
J. Grecula,
A. Arnett,
D. Blakaj,
J. McGregor,
J. Elder,
...
Lanchun Lu,
W. Zoller,
M. Addington,
R. Lonser,
A. Chakravarti,
P. Brown,
R. Raval
|
5 |
2019 |
5 π
|
π
|
Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: a prospective multi-center study
23 auth.
E. Gez,
S. Cytron,
R. B. Yosef,
D. London,
B. Corn,
S. Alani,
G. Scarzello,
F. Dal Moro,
G. Sotti,
F. Zattoni,
...
I. Koziol,
T. Torre,
M. Bassignani,
S. Kalnicki,
R. Ghavamian,
D. Blakaj,
M. Anscher,
M. Sommerauer,
D. Jocham,
Corinna Melchert,
S. Huttenlocher,
G. Kovacs,
M. Garg
|
5 |
2013 |
5 π
|
π
|
A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma
17 auth.
T. Teknos,
J. Grecula,
Amit Agrawal,
M. Old,
E. Ozer,
R. L. Carrau,
Stephen Y. Kang,
James W. Rocco,
D. Blakaj,
V. Diavolitsis,
...
Bhavna Kumar,
Pawan Kumar,
Quintin Pan,
M. Palettas,
Lai Wei,
R. Baiocchi,
P. Savvides
|
5 |
2018 |
5 π
|
π’
|
Emerging Concepts and Novel Strategies in Radiation Therapy for Laryngeal Cancer Management
M. Gamez,
A. Blakaj,
W. Zoller,
M. Bonomi,
D. Blakaj
|
4 |
2020 |
4 π’
|